9999999997-15-011264.txt : 20150630 9999999997-15-011264.hdr.sgml : 20150630 20150630092046 ACCESSION NUMBER: 9999999997-15-011264 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150630 DATE AS OF CHANGE: 20150630 20150630 20150630 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Enumeral Biomedical Holdings, Inc. CENTRAL INDEX KEY: 0001561551 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 990376434 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-55415 FILM NUMBER: 15960078 BUSINESS ADDRESS: STREET 1: 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: (617) 674-1865 MAIL ADDRESS: STREET 1: 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: CERULEAN GROUP, INC. DATE OF NAME CHANGE: 20121102 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0R(#`@;V)J#3P\+TQI;F5AF4@-34O5'EP92]84F5F+U=;,2`R(#%=/CYS=')E86T-"FC>8F)D$&!@ M8F#R`A(,4X`$XWT@P1(()-AS@<2GEPQ,C`P[0;(,C.C$?\99?P`"#`#5)@?D M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@ M("`@#0HU-"`P(&]B:@T\/"]#(#8Y+T9I;'1E8F!@8&%@8(IF``*>_0RH@)$! M),O1@"S&`L4,#/<9N!DX3[NS&$"5\J^%T$Q3D14KK8"(,IH#!!@`*8<&5PT* M96YD7!E+T]B M:E-T;3X^>>Z MD,S0V39;-T0J.JO*=C*I?CU<:&W11P1C#`L\HG>6[8KMR[M%LUGF[W-#;JMYE6S3==XP,8_2FS;;% M\KI<;W/"Z+S-=]\(EPE=O#SE&`N4Z^*IK6KZO=^)TN;JRNT3]@TAQ[[^L5Q6 MJZ)#$`'`:%A+@"7Z?]!9"'<,& M.'LJ&3%"N"$S^/3KA/-`4MH48V$-OE2I+A;>?9Q[USK9JX,;B8O*:%/:\D`, M2;IDY0K[9VP/.?W:]FOO#SF.J(Q\2*IO`/I3181@^-3PU'US=,3#GT#0-9S,$XGI/>9P8:;`YM*T2]] M4XUK@AJ8=?8NW^@!.CJD,<()XDA$P(U$"$D'9AS(^A$9`\8GG.0!0`PT:0R8 M@AAA$@[54>G>I`0,.8\H2T%^G<;^I?PF^_++S'GR^Z;RJB/*:]EIX57VI/"> MJ[GB?]9CJYRHLR4WS*:KX0&SFPJ^=Z?B>^#O!7+H[Q7X;'3' M?!SDHN1R'GQ!FON\6'%5D@8Q0:7M53&H8R1`\;T2_AX?^J4X7G%/QHJK7#\% MK"W<0WY0<2'NM.+"[E%P.7\EN%X17@EN:L_0VXB!26#K21@#;SNEMTK+?;WE MK_56143V]\"#`"Y M!WQD#0IE;F1S=')E86T-96YD;V)J#30V(#`@;V)J#3P\+T9I;'1E,S.Z*#KG/XOW[\]O^S<#$8H/'RX&?=$Y[]^'8K*!";&9+#OG11$*)8K' MCM(B"&$:_N>A2,-,YHDH%AU/^,4?G5T>-O$]^[`WA=^-KK[@"7G_U5>CUK_V@Z_6&/_AFK^C_A#.W?I#!0_-VVDD/>B6) M8<.9PR[$UH549GO6?MRADB4^9G[7$U%X)G2H8M)Z6%?BPJ%B&>:G[C@]$KU8 MYG'=&O+H;D`1N!,8C+L>7%SH#:L84HP$S7*,AE=^SDN\L2;;^Y%B21-WL*AB MKTJ87[GS*PJECD]=JPKKC-2.D10'!1KVXH"Q1Y1I;X>/ MA0\W,0-GGN'W`'[Q_0]PEN""18%DM(E>^ M`G_1_CD^B'Q#\&0E!7,O1(4`1IN:`GP/9129]SCN`DUACH_F]:B2IUF,`]C, M&,7!BQAY?8AC[EU]U_+=[8WX+`<832?$>52=UW+59>@@E[J>%7[G/]KZ^][? M$6TNYT(54ER%`J5ERKB,*@_?V.\27O&]$3D`T\CBXM*/`!`(3L`FXS(&S"6$ MRQQA:>:G,"@)AHQ*E+B&JR/2Z8'#M?KN1-%[3BW=3.KI=@MI[CQ&=PV M:+O#X\"\+'?G5;C4I+D[9E$#M,B!XZWP!A'D'%T'/885P_BGB36.-[[RMB71 MD<(F,+(8<`SD(VPHIT82)[8E!WW[C"2>F4O8+MRZP"VX'<\2I55"%X13"Y(O M[0&BW`K<^Y72`:I&N^R)^)\4/ANE"[%],FL"04/;G@@4$*$Q#K;HD-BBM,"S MQ)6?.8,6HD$ZA*<**P*KBN"_<%C3O80T`F^B1MZ8"KA2EP!M1=),=N@@M((@ M!5'BO39/]SB#(!9U2)=L*[\\PJVJ`8"4<;I0I"TJ.MY=^"F!0\DA2/48)2= M9O3.#*PII+:B;9N`6(P3`SBX7[KS%<%%K!XI12*D.%GC^\H!='$(B*+G,UIH M\@QZ[T\P(>\Q5K*/_9T4<:P_>Z!@_-F')PV[-#SCPVCK$R7?@6\T_T5/8H$] MB%@D&EP147YR8K8)(N5[0NZ+D2 MZ]UXO^#0F^$@NC.M3'?+*\=G4=4T*4STP$*4)'\,P4@3L6Q.A'PEDS5P**_U M=[`L4.E74Z7-:;LI6\ZJZ!:-9^K`#>(Z+AL4U&[#T(D.K=&)%,Y=5EZ]V$OC MM%"SZ(FFQ\9ESA:Y/DGN%U!0SN<"@;W",KD58XMH6U7GMAQN,(>X^L6EJ"+` MVC`;]\^IN]ZOF97DMD3&`AUISPP!C!)$M6FS>U38XS1:3V[&S0#=V9M/7 MYH3"4>)-/QI,`RJGN/:NH;LKH1\\UI57WV01E*3T9$ERWSIA4S2JGW/HA#KA[*^X@X^W[,=PI0<5,L@(]3M"#1/K,V4_5N,$=0?E1ABJ2X6 M;9615-8XI>FQ#JN:G:#LOW7[?WQI^5)]@T6M+[!C77Z]$:NA'#^'3'VBDHD_ M4TWV89A)Z&5<\UYO-+:41O[S?'T&F18WD,[=@VN%;!YV/6"#=]`8H>FU?$4T MF\U9,>=52!U;?F]]MHS,)\:.,4I&VYSM$C&%*)6)_89\Q]>A\Z-WJ=U=0@=P MDK@Z:O62+9'N:9'VQ^&W0BRWM+9W-;?SD3I365WKS%:E*?>+LP]@QCETCWW6;/),U9H0\F#Z'_RP>&UP)))I5M>LI=9'74LKUUI9J26< M';[;RZ+SMP`#`'2L"_(-"F5N9'-TY!@9$1FEP'Z>@8V!F0$,$I.+"QP#`GQ`[+S\ MO%0&#/#M&@,CB+ZL"S(+4QXO8$TN*"H!T@>`V"@EM3@92'\!XLSRD@*@.&," MD"V2E`UF@]2)9(<$.0/9'4`V7TEJ!4B,P3F_H+(H,SVC1,'0TM)2P3$E/RE5 M(;BRN"0UMUC!,R\YOZ@@ORBQ)#4%J!9J!PCPNQ`P8A0[CQ!#@.32HC(HDY')F($!(,``2<8X+PT*96YDW)/! M;MLP#(9?A(G.\B@!$_@@3(/%1"68#,H"@?60NDRL`@^0["PO(O(+#Q+S"E4#,<[Q+8IXK"(AYCM]'S"N)#\&\TB,0\SS# MB7G>\1&95_&Q.&(KWN?%A;GEXV=P9];-&+JX&4/@5OP[L0JO\38M^,T=RTNVD,YG/;\/KS>3CVPW4SO`V7W1/#@UFEOQON\I_1E^[0=J'> M-VSBE/X^Q30GVV`[[:_03_$TG!Y?MF,[G(=#&/^>V+#IJ_XU[=[<=T]A/),6 MB_])ZGSO,_.UZ78?EJM/]_5'UGSZ#G:0YR?A:[G.?/&U250G29W,UG6RTG?^'9+TEJQ>D]5[LGI15F_*ZE59O2NKEV7UME!O"]_Q3>EMH=X6 MZFVAWA;J;:'>%JIL_19@`%BS%]\-"F5N9'-T7!E+UA-3"]4>7!E+TUE=&%D871A/CYS M=')E86T-"CP_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ MDY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N-"UC,#`U(#&UL;G,Z&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N M8V]M+WAA<"\Q+C`O(@H@("`@("`@("`@("!X;6QN&UL;G,Z M9&,](FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT&UP.D-R96%T941A=&4^,C`Q-2TP-BTS,%0P.3HQ-3HU-BTP-#HP,#PO>&UP M.D-R96%T941A=&4^"B`@("`@("`@(#QX;7`Z365T861A=&%$871E/C(P,34M M,#8M,S!4,#DZ,34Z-3DM,#0Z,#`\+WAM<#I-971A9&%T841A=&4^"B`@("`@ M("`@(#QX;7`Z0W)E871O&UP.D-R96%T;W)4;V]L/@H@("`@("`@("`\>&UP34TZ1&]C=6UE M;G1)1#YU=6ED.C%A-&-F,S&UP34TZ1&]C=6UE;G1)1#X*("`@("`@("`@/'AM<$U-.DEN7=O#I3;W5R8V5-;V1I9FEE9#X*("`@("`@("`@/'!D M9G@Z0V]M<&%N>3Y396-U&AA;F=E($-O;6UI3X*("`@("`@("`@/'!D9G@Z0V]M;65N=',^5F5R'L/WOL?,-2"L M5O4FIQ.+RK&JMWRY4$A1/9%$SP'T-7Y?WTT8U8%L%I\\13#!P>WGR807@JGD MXX075,BDDGJ32/7+&]0M+AK$3K?MX@KG,\39#U4F-U9X,`GV_=W.G$E`:SBR MP#.+J^I[&C]*B*JJ=^S^,W:_QKVPRY:*TO%`DQ`>_"!&QN* MW!^1;G3;=`7(PRO95,8>?7HC5:W77P(,`):N6%D-"F5N9'-T